Clin2
NCT07563322Possibly a fitRecruiting

Nicotinamide Riboside for Combined Pulmonary Hypertension

Pulmonary Hypertension

Treatments studied

Part of Heart & circulation, Lungs & breathing clinical trials.

This study tests whether nicotinamide riboside (a B-vitamin supplement) can help people with combined pulmonary hypertension—a condition where blood pressure in the lungs is too high. The researchers want to understand how this supplement affects the body's energy metabolism and whether it might reduce symptoms and improve heart function.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You are between 18 and 85 years old
  • You have been diagnosed with combined pulmonary hypertension (high lung blood pressure with specific measurements confirmed by heart catheterization within 2 years)
  • Your heart function is stable (ejection fraction ≥45%) based on an echocardiogram in the past year
  • You are able to walk and perform daily activities without major mobility aids
  • Your liver and kidney function are normal or near-normal (no severe liver disease, kidney function eGFR ≥30)
  • Your lung function is not severely reduced (FEV1 ≥60% predicted)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03821623Recruiting· Phase 2
Vitamin-like nicotinamide riboside for higher blood pressure

This trial tests whether nicotinamide riboside can improve elevated blood pressure and blood vessel stiffness in middle-aged and older adults. You may be randomly assigned to take the study medicine or not, and the team will check your heart/blood vessel measurements over time.

Boulder, Colorado
NCT07693543Not yet recruiting· Phase 2
Nicotinamide riboside supplement for chronic kidney disease

This trial tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3) can help people with moderate chronic kidney disease. It aims to see if it can slow down kidney function decline and improve overall health.

San Diego, California
NCT06425042Recruiting
Nicotinamide riboside with exercise for healthy aging

This study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3), combined with a supervised exercise program, can help promote healthy aging and improve how well your body functions. You would take the supplement or a placebo for 12 weeks while doing light to moderate exercise.

Santiago, Santiago Metropolitan
NCT06345443Enrolling by invitation
Nicotinamide riboside for blood vessel health

This trial tests a nutritional supplement (nicotinamide riboside) to see how it affects blood flow in healthy adults. It may help understand how to support vascular health as we age.

Rochester, Minnesota
NCT07284225Not yet recruiting
Nicotinamide riboside's effect on sleep in healthy adults

This trial is testing whether a supplement called nicotinamide riboside can safely and quickly improve sleep structure in healthy adults who have mild sleep trouble. If you have some difficulty sleeping but are otherwise healthy, this study might help us learn more about a new option to support better sleep.

NCT06853743Recruiting· Phase 2
Study of nicotinamide riboside for Huntington's disease

This trial tests if a vitamin B3-like supplement, nicotinamide riboside, can help people with early to mid-stage Huntington's disease. You will be randomly assigned to take the supplement or a placebo to see if it slows the disease.

Oslo

Hear when a new Pulmonary Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.